MedTrace Logo

Effect of Corona Virus on Intravitreal Injections

NCT05494775 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 250

Last updated 2022-08-10

No results posted yet for this study

Summary

During pandemic of corona virus, patients compliance may be affected. We aim to study the factors lead to unregulated visits and its implications on the final visual outcome.

Conditions

Interventions

DRUG

Anti-vascular endothelial growth factors (Anti-VEGFs)

Intravitreal injection of anti-vascular endothelial growth factors (Anti-VEGFs).

Sponsors & Collaborators

  • Benha University

    lead OTHER

Principal Investigators

  • Ahmed A Tabl · Benha University

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-02-01
Primary Completion
2023-06-11
Completion
2023-07-30

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05494775 on ClinicalTrials.gov